메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Kim, Jihyun (Department of Life and Nanopharmaceutical Science, Kyung Hee University) Kim, Jaehoon (Department of Life and Nanopharmaceutical Science, Kyung Hee University) Huang, Zhouchi (College of Pharmacy and Integrated Research Institute of Parmaceutical Sciences, The Catholic University of Korea) Goo, Nayeon (Department of Life and Nanopharmaceutical Science, Kyung Hee University) Bae, Ho Jung (Department of Life and Nanopharmaceutical Science, Kyung Hee University) Jeong, Yongwoo (Department of Life and Nanopharmaceutical Science, Kyung Hee University) Park, Ho Jae (Department of Oriental Pharmaceutical Science, Kyung Hee University) Cai, Mudan (Department of Life and Nanopharmaceutical Science, Kyung Hee University) Cho, Kyungnam (Department of Life and Nanopharmaceutical Science, Kyung Hee University) Jung, Seo Yun (Department of Life and Nanopharmaceutical Science, Kyung Hee University) Bae, Soo Kyung (College of Pharmacy and Integrated Research Institute of Parmaceutical Sciences, The Catholic University of Korea) Ryu, Jong Hoon (Department of Life and Nanopharmaceutical Science, Kyung Hee University)
저널정보
한국응용약물학회 Biomolecules & Therapeutics(구 응용약물학회지) Biomolecules & therapeutics 제27권 제3호
발행연도
2019.1
수록면
327 - 335 (9page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
As the elderly population is increasing, Alzheimer's disease (AD) has become a global issue and many clinical trials have been conducted to evaluate treatments for AD. As these clinical trials have been conducted and have failed, the development of new theraphies for AD with fewer adverse effects remains a challenge. In this study, we examined the effects of Theracurmin on cognitive decline using 5XFAD mice, an AD mouse model. Theracurmin is more bioavailable form of curcumin, generated with submicron colloidal dispersion. Mice were treated with Theracurmin (100, 300 and 1,000 mg/kg) for 12 weeks and were subjected to the novel object recognition test and the Barnes maze test. Theracurmin-treated mice showed significant amelioration in recognition and spatial memories compared those of the vehicle-treated controls. In addition, the antioxidant activities of Theracurmin were investigated by measuring the superoxide dismutase (SOD) activity, malondialdehyde (MDA) and glutathione (GSH) levels. The increased MDA level and decreased SOD and GSH levels in the vehicle-treated 5XFAD mice were significantly reversed by the administration of Theracurmin. Moreover, we observed that Theracurmin administration elevated the expression levels of synaptic components, including synaptophysin and post synaptic density protein 95, and decreased the expression levels of ionized calcium-binding adapter molecule 1 (Iba-1), a marker of activated microglia. These results suggest that Theracurmin ameliorates cognitive function by increasing the expression of synaptic components and by preventing neuronal cell damage from oxidative stress or from the activation of microglia. Thus, Theracurmin would be useful for treating the cognitive dysfunctions observed in AD.

목차

등록된 정보가 없습니다.

참고문헌 (44)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0